Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatment results.
| Docetaxel + capecitabine (T) | Paclitaxel + capecitabine (W) | |
|---|---|---|
| Mean dose given (mg/m2) (% of planned dose) | ||
| Docetaxel | 75.6 (94.6) | |
| Paclitaxel | 81.0 (101) | |
| Capecitabine | 1962.8 (98.1) | 1990 (99.5) |
| Best response | ||
| CR | 0/19 | 1/18 |
| PR | 4/19 | 12/18 |
| SD | 10/19 | 3/18 |
| PD | 4/19 | 1/18 |
| Not evaluable for response | 1/19 | 1/18 |
| Main Reason for TTF | ||
| Disease progression | 9/19 | 8/18 |
| Toxicity | 8/19 | 8/18 |
| Patient's request | 2/19 | 2/18 |
| TTF days | 147 | 174 |
| OS days | 464 | 933 |
